Significance of 99mTc-Sestamibi myocardial scintigraphy after percutaneous coronary intervention in patients with acute myocardial infarction
暂无分享,去创建一个
M. Banach | K. Yoneyama | F. Miyake | Y. Ishibashi | M. Takano | K. Kida | Kengo Suzuki | Y. Akashi | M. Izumo | K. Ashikaga | Masaki Izumo
[1] D. Atsma,et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. , 2009, The American journal of cardiology.
[2] Stanley Chia,et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. , 2008, JACC. Cardiovascular interventions.
[3] J. Ottervanger,et al. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. , 2008, American heart journal.
[4] V. Guetta,et al. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. , 2008, The American journal of cardiology.
[5] D. Okada,et al. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[6] M. Horie,et al. A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[7] M. Runge,et al. Mitochondrial Dysfunction in Atherosclerosis , 2007, Circulation research.
[8] R. Califf,et al. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. , 2006, American heart journal.
[9] S. Petersen,et al. Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.
[10] C. Orlandi,et al. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention , 2005, European Journal of Nuclear Medicine.
[11] R. Giubbini,et al. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. , 2002, Clinical chemistry.
[12] T. Takano,et al. Assessment of myocardial washout of Tc-99m-sestamibi in patients with chronic heart failure: Comparison with normal control , 2002, Annals of nuclear medicine.
[13] Y. Takeishi,et al. Reverse redistribution of 99mTc-sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation , 2001, Nuclear medicine communications.
[14] R. Kim,et al. Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.
[15] O. Tochikubo,et al. Early peak creatine kinase activity is not always a marker of successful reperfusion with myocardial salvage in patients with reperfused anterior acute myocardial infarction. , 2001, American heart journal.
[16] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[17] M. Yamaki,et al. Prediction of functional recovery in acute myocardial infarction: Comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[18] Y. Takeishi,et al. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[20] D. Berman,et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] J. Leppo,et al. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: Comparison by quantitative dual-tracer autoradiography in rabbits , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[22] B. Holman,et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J. Kronauge,et al. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] J. Kronauge,et al. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.
[25] J. Kronauge,et al. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] R. Sciagrà,et al. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. , 1990, Journal of the American College of Cardiology.
[27] M. Akers,et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.
[28] R. Nohara,et al. Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man. , 1983, Journal of the American College of Cardiology.
[29] P. Thompson,et al. Enzymatic Indices of Myocardial Necrosis: Influence on Short- and Long-Term Prognosis After Myocardial Infarction , 1979, Circulation.
[30] B. Sobel,et al. Estimation of Infarct Size in Man and its Relation to Prognosis , 1972, Circulation.